ASN's Mission

To create a world without kidney diseases, the ASN Alliance for Kidney Health elevates care by educating and informing, driving breakthroughs and innovation, and advocating for policies that create transformative changes in kidney medicine throughout the world.

learn more

Contact ASN

1401 H St, NW, Ste 900, Washington, DC 20005

email@asn-online.org

202-640-4660

The Latest on X

Kidney Week

Abstract: TH-PO228

Extracorporeal Carbon Dioxide Removal Instead of Mechanical Ventilation in a Patient with Respiratory Distress and Acute Kidney Failure, with Active Bleeding Using Regional Anticoagulation

Session Information

Category: Dialysis

  • 801 Dialysis: Hemodialysis and Frequent Dialysis

Authors

  • Kalil, Milton, Hospital Moinhos de Vento, Porto Alegre, RS, Brazil
  • Eick, Renato Eorgeg, Hospital Moinhos de Vento, Porto Alegre, RS, Brazil
  • Saitovich, David, Hospital Moinhos de Vento, Porto Alegre, RS, Brazil
  • Stein, Anna Cristina, Hospital Moinhos de Vento, Porto Alegre, RS, Brazil
  • Da Luz, Lucas G., Hospital Moinhos de Vento, Porto Alegre, RS, Brazil
  • Balestrin, Illan George, Hospital Moinhos de Vento, Porto Alegre, RS, Brazil
  • Gazzana, Marcelo Basso, Hospital Moinhos de Vento, Porto Alegre, RS, Brazil
  • André, Mauricio Lutzky, Hospital Moinhos de Vento, Porto Alegre, RS, Brazil
Introduction

There are only a few reports so far describing the use of citrate (regional) anticoagulation for CO2 removal (ECCO2R) probably due to the
metabolic complications and electrolyte disturbances that occur with the high blood flow rate (for efficient CO2 removal) and higher than usual citrate flow rate, necessary for the procedure.

Case Description

Citrate anticoagulation in continuous venovenous hemodiafiltration (CVVHDF) associated with extracorporeal carbon dioxide removal (ECCO2R) was performed in a 71 years old patient with active bleeding and severe respiratory acidosis for 5 days. This procedure was carried out with a Fresenius (multiECCO2R), a single gas exchanger combined with continuous kidney replacement therapy (CKRT). Dialysis prescription was blood flow rate of 300ml/min, sodium citrate 4% infusion rate of 300ml/h, calcium chloride 3.38% replacement solution rate of 30ml/h, and oxygen flow rate of 4.5L/min. Dialysis and replacement solutions bicarbonate and sodium concentration were respectively 10mEq/L and 129mEq/L.The patient remained without endotracheal intubation during the procedure period. A reduction of approximately 30% pCO2 was attained, respiratory acidosis was controlled and the hydroelectrolytic balance was maintained(Table1).

Discussion

In cases of CO2 removal in the context of regional anticoagulation with citrate, it is important to adjust calcium replacement according to effluent volume and also to adjust bicarbonate and sodium concentrations in dialysis solutions. We conclude that it is possible and safe to remove CO2 in a CVVHDF + multi ECCO2R single system, using sodium citrate for regional anticoagulation.